Table 1.
Comparison of Receptor Models Used for FEP+ Calculationsa
target | input protein structure for FEP+ |
resolution (Å) | whole protein identity (%) |
binding site identity (%) |
binding site RMSD (Å) backbone/side chains |
---|---|---|---|---|---|
T4 lysozyme L99A | 181l | 1.80 | |||
184l | 1.80 | 100 | 100 | 0.29/0.42 | |
2oty | 1.83 | 100 | 100 | 1.62/2.00 | |
BRD4 | 3mxf | 1.60 | |||
hm-3s91 (BRD3) | 2.06 | 80 | 91 | 1.65/1.83 | |
hm-3oni (BRD2) | 1.61 | 38 | 60 | 1.68/1.69 | |
MCL-1 human | 4hw3 | 2.40 | |||
hm-2nl9 (MCL-1 rat) | 1.55 | 87 | 63 | 2.11/2.67 | |
hm-4lvt (Bcl-xL) | 2.05 | 22 | 35 | 2.67/3.28 | |
Tyk2 | 4gih | 2.00 | |||
hm-3eyg (JAK1) | 1.90 | 58 | 79 | 0.89/1.57 | |
hm-3eqr (ACK1) | 2.00 | 38 | 36 | 1.11/2.04 | |
hm-1byg (CSK) | 2.40 | 31 | 21 | 1.84/3.28 | |
3nyx | 2.50 | 100 | 100 | 2.61/3.03 | |
A2A | 4eiy | 1.80 | 100 | ||
hm-4amj (β1-AR) | 2.30 | 28 | 28 | 5.79/7.38 |
The second column either shows the PDB code of the crystal structure or the PDB structure used as template for building a homology model (with prefix “hm”). The target name is specified in parentheses if not identical to the original target. The “binding site” is defined as all residues within 5 Å of the cocrystallized ligand. Identity and RMSD measurements are relative to the first structure listed for each target.